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ABSTRACT 65 
GJA8 encodes connexin 50 (Cx50), a transmembrane protein involved in the formation of 66 
lens gap junctions. GJA8 mutations have been linked to early onset cataracts in humans and 67 
animal models. In mice, missense mutations and homozygous Gja8 deletions lead to smaller 68 
lenses and microphthalmia in addition to cataract, suggesting Gja8 may play a role in both 69 
lens development and ocular growth.  70 
Following screening of GJA8 in a cohort of 426 individuals with severe congenital eye 71 
anomalies, primarily anophthalmia, microphthalmia and coloboma, we identified four known 72 
(p.(Thr39Arg), p.(Trp45Leu), p.(Asp51Asn) and p.(Gly94Arg)) and two novel (p.(Phe70Leu) 73 
and p.(Val97Gly)) likely pathogenic variants in seven families. Five of these co-segregated 74 
with cataracts and microphthalmia, whereas the variant p.(Gly94Arg) was identified in an 75 
individual with congenital aphakia, sclerocornea, microphthalmia and coloboma. Four 76 
missense variants of unknown or unlikely clinical significance were also identified. 77 
Furthermore, the screening of GJA8 structural variants in a subgroup of 188 individuals 78 
identified heterozygous 1q21 microdeletions in five families with coloboma and other ocular 79 
and/or extraocular findings. However, the exact genotype-phenotype correlation of these 80 
structural variants remains to be established.  81 
Our data expand the spectrum of GJA8 variants and associated phenotypes, confirming the 82 
importance of this gene in early eye development. 83 
Key words: Cataract, microphthalmia, coloboma, congenital aphakia, GJA8, Cx50 84 
  85 
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INTRODUCTION 86 
Anophthalmia (absent eye), microphthalmia (small eye) and coloboma (optic fissure closure 87 
defects), collectively referred to as AMC, form a spectrum of developmental eye disorders, 88 
with an overall estimated incidence of 6-13 per 100,000 births (Shah et al., 2011; Skalicky et 89 
al., 2013). AMC can occur alone or in combination with other ocular anomalies, such as early 90 
onset cataract and anterior segment dysgenesis (ASD). They are associated with extraocular 91 
features in just over half of cases (Shah et al., 2012) and can form part of a syndrome 92 
(Slavotinek, 2011). The etiology of AMC is characterised by marked genetic heterogeneity. 93 
This reflects the complexity underlying eye morphogenesis, a conserved process that requires 94 
a series of highly coordinated events, both at the molecular and the structural level, and is 95 
tightly regulated by a network of transcription factors, extracellular signaling molecules, cell-96 
cycle regulators and adhesion proteins (Reis and Semina, 2015). 97 
Connexins (Cxs) are a homogeneous family of transmembrane proteins with a crucial role in 98 
intercellular communication. They present a conserved topology, which consists of four 99 
transmembrane α-helices (TM1-TM4) joined by two extracellular loops (ECL1 and ECL2) 100 
and one cytoplasmic loop (ICL), flanked by a short cytoplasmic N-terminal domain (NT) and 101 
a long cytoplasmic and less conserved C-terminal domain (CT). Cxs oligomerise in 102 
hexameric complexes called connexons, and allow the transmembrane passage of ions and 103 
small solutes (≤1 kDa). Connexons can function independently as hemichannels (HCs) or 104 
they can dock with their counterparts on the juxtaposed cell to form a gap junction channel 105 
(GJC), enabling the direct exchange of small molecules. Given their role in cell-cell 106 
communication and tissue homeostasis, Cxs have been implicated in a variety of biological 107 
and pathological processes (Pfenniger et al., 2011; García et al., 2016), including myelin-108 
related diseases (Cx32 and Cx47), heart malformations and arrhythmia (Cx40), hearing loss 109 
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and skin disorders (Cx26, Cx30, Cx30.3 and Cx31), oculodentodigital dysplasia, a syndrome 110 
also involving microphthalmia, microcornea, cataract and/or spherophakia (Cx43), and early 111 
onset cataract (Cx46 and Cx50).  112 
As with AMC, developmental or early onset cataracts are a clinically heterogeneous group of 113 
disorders, presenting as isolated anomalies or part of a syndrome. More than 110 genes have 114 
been implicated in congenital cataracts (Gillespie et al., 2014), with mutations in Cxs 115 
accounting for around 16% of cases with a known genetic cause (Shiels and Hejtmancik, 116 
2017). Since the lens does not have any blood supply, it strongly depends on an extensive 117 
network of GJCs for the intercellular communications that are critical for its development and 118 
the maintenance of its transparency. The most abundant Cxs in the lens are Cx46 and Cx50, 119 
which can also form mixed hexamers. Cx46, encoded by GJA3, is expressed only in fiber 120 
cells, whereas Cx50, encoded by GJA8, is present throughout the lens.  121 
Genetic studies in mice have demonstrated that the homozygous knockout of either Gja3 or 122 
Gja8 leads to cataracts, but with important phenotypic differences. The deletion of Gja3 123 
causes severe progressive nuclear cataracts, but does not alter ocular growth (Gong et al., 124 
1997). In contrast, Gja8-null mice develop milder nuclear cataracts at an early postnatal age 125 
and exhibit significantly smaller lenses and microphthalmia (White et al., 1998; Rong et al., 126 
2002), indicating that the two Cxs have overlapping, but distinct functions. In addition, the 127 
targeted replacement of Gja8 with Gja3 (Cx50KI46 knockin mice) prevents the loss of 128 
crystalline solubility, but not the postnatal growth defect resulting from the Gja8 deletion 129 
(White, 2002), confirming the functional diversity of the two proteins and the involvement of 130 
Gja8 in the control of normal ocular growth. This is also supported by mouse lines carrying 131 
missense mutations in Gja8 (Steele et al., 1998; Graw et al., 2001; Chang et al., 2002; Xia et 132 
al., 2012; Berthoud et al., 2013) and by rabbit models with CRISPR-Cas9 mediated GJA8 133 
knockout (Yuan et al., 2016): both develop cataracts, microphthalmia and smaller lenses. 134 
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Moreover, severe cataracts and small lenses have also been observed in transgenic mice 135 
overexpressing Gja8 (Chung et al., 2007), indicating that any significant dysregulation of 136 
Gja8 could be deleterious for eye development.  137 
In humans, missense and frameshift mutations in GJA8 (OMIM 600897) have been 138 
associated with cataracts (Beyer et al., 2013; Yu et al., 2016). Rarely, the phenotype also 139 
includes additional ocular abnormalities, mainly microcornea and iris hypoplasia (Devi and 140 
Vijayalakshmi, 2006; Hansen et al., 2007; Hu et al., 2010; Sun et al., 2011; Prokudin et al., 141 
2014; Ma et al., 2016), but in a few cases also microphthalmia (Ma et al., 2016) and 142 
sclerocornea (Ma et al., 2018). Interestingly, defects in the formation of the lens have also 143 
been observed (Ma et al., 2018). The cataracts described in these individuals vary in both 144 
their location (e.g., nuclear, zonular, lamellar or total) and appearance (e.g., total, pulverulent 145 
or dense). The mutations are predominantly heterozygous and only few homozygous variants 146 
have been reported, all in consanguineous families (Ponnam et al., 2007; Schmidt et al., 2008 147 
Ponnam et al., 2013; Ma et al., 2016). These pathogenic variants lead to amino acid 148 
alterations distributed throughout the protein (Yu et al., 2016), although mostly localised 149 
between the domains TM1 and TM2. They are predicted to affect protein function through 150 
various mechanisms, such as by inducing misfolding and/or mislocalisation or by altering 151 
channel properties (Beyer et al., 2013). 152 
Copy number variants (CNVs) in the distal region of chromosome 1q21 and including GJA8 153 
are rare in the general population, but have recurrently been identified in individuals with a 154 
broad range of different clinical diagnoses (Brunetti-Pierri et al., 2008; Mefford et al., 2008; 155 
Stefansson et al., 2008 Bernier et al., 2016). These primarily include developmental delay, 156 
microcephaly and psychiatric disorders, although the enrichment of 1q21 CNVs in 157 
individuals with these disorders could partly be related to ascertainment bias. However, some 158 
cases also have eye anomalies, such as cataracts (Brunetti-Pierri et al., 2008; Mefford et al., 159 
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2008; Rosenfeld et al., 2012; Bernier et al., 2016; Ha et al., 2016), microphthalmia (Mefford 160 
et al., 2008) and coloboma (Brunetti-Pierri et al., 2008). Among the genes affected by these 161 
recurrent microdeletions/microduplications, GJA8 represents a strong candidate for the ocular 162 
anomalies described in some of the 1q21 CNV carriers. 163 
To investigate further the importance of GJA8 in human eye morphogenesis and provide a 164 
better understanding of the range of developmental ocular anomalies associated with 165 
mutations in this gene, we screened GJA8 in a cohort of 426 unrelated patients (304 UK, 121 166 
Spanish and 1 large French pedigree) with congenital eye anomalies in the AMC spectrum. 167 
Two novel and four known likely pathogenic sequence variants were identified in seven 168 
families, with one variant being present in two unrelated families. This expands the catalogue 169 
of GJA8 variants likely to be contributing to eye anomalies and the spectrum of phenotypes 170 
associated with this gene. Moreover, we also identified heterozygous 1q21 microdeletions 171 
including the gene GJA8 in five additional families, although the pathogenicity of these 172 
variants remains to be established.  173 
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MATERIALS AND METHODS 174 
Cohort description. 175 
A cohort of UK, Spanish and French families with AMC (Supplementary Table 1) was 176 
analysed for GJA8 variants. The UK families (n=304) were recruited as part of a national 177 
‘Genetics of Eye and Brain anomalies’ study, approved by the Cambridge East Ethics 178 
Committee (04/Q0104/129) and had not received a genetic diagnosis. Family 5 was also 179 
recruited into the Deciphering Developmental Disorders (DDD) Study, which has UK 180 
Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, 181 
and GEN/284/12 granted by the Republic of Ireland REC). The UK families consisted of 55 182 
probands with anophthalmia, 205 with microphthalmia and 44 with other anomalies within 183 
the AMC spectrum; 168 individuals were bilaterally affected and 160 had extra-ocular 184 
anomalies. The Spanish families (n=121) consisted of 6 individuals with anophthalmia, 42 185 
with microphthalmia and 73 with other anomalies within the AMC spectrum; 100 individuals 186 
were bilaterally affected and 41 had extra-ocular anomalies. They were consented for genetic 187 
studies approved by the Ethics Committee of the University Hospital Fundación Jiménez 188 
Díaz (FJD, Madrid, Spain) and according to the tenets of the Declaration of Helsinki. The 189 
four-generation French pedigree consisted of 15 individuals with congenital cataracts and 190 
microphthalmia and consented for the study during their clinical treatment.  191 
Identification of sequence and structural variants in GJA8. 192 
The human gene GJA8 presents one isoform (NM_005267.4), comprising of two exons, with 193 
the coding sequence (CDS) entirely contained within exon 2. Sequence variants in the CDS 194 
were detected using a combination of Next-Generation Sequencing (NGS) methods and 195 
direct sequencing: 35 patients were screened by whole exome sequencing (WES), 207 196 
patients using different targeted NGS panels of eye development genes including GJA8, and 197 
184 patients by Sanger sequencing, which was also used to validate NGS findings and check 198 
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family segregation. Additionally, CNV data was available for 188 of these patients: 151 199 
individuals (96 UK and 55 Spanish) had been assessed by array-based Comparative Genomic 200 
Hybridization (aCGH), with resolutions ranging from 44 kb to 244 kb, whereas for 37 201 
Spanish individuals, CNVs were detected from NGS data using a read depth comparison 202 
approach. A detailed description of the different methods can be found in the Supplementary 203 
Materials and Supplementary Table 1. The genomic coordinates of the sequence and 204 
structural variants are reported according to Build GRCh37/hg19. The allelic frequencies of 205 
the sequence mutations were obtained from the Genome Aggregation Database (gnomAD, 206 
http://gnomad.broadinstitute.org/) (Lek et al., 2016). For each variant of interest, amino acid 207 
conservation across species was visually inspected using the Vertebrate Multiz Alignment & 208 
Conservation (100 Species) track from the UCSC Genome Browser. Three conservation 209 
scores were annotated using the database dbNSFP v.3.3 (Liu et al., 2016), specifically the 210 
GERP++ Rejected Substitutions (RS) score (Davydov et al., 2010), phyloP 211 
100way_vertebrate score (Siepel et al., 2006) and phastCons 100way_vertebrate score (Siepel 212 
et al., 2005). Putative functional effects of amino acid substitutions were evaluated with the 213 
in silico tools SIFT (Kumar et al., 2009) and PolyPhen-2 (Adzhubei et al., 2010).  214 
Validation of mosaicisms and CNVs. 215 
In order to assess potential mosaicism and independently validate aCGH findings, we 216 
developed Digital Droplet PCR (ddPCR) assays for the sequence variant in family 1 and three 217 
of the GJA8 microdeletions identified (families 12, 13 and 14) (Supplementary Materials). 218 
ddPCR assays were performed using a ddPCR QX200 System (Bio-Rad Laboratories). 219 
Primers and Taqman probes were specifically designed for the GJA8 variant p.(Thr39Arg) 220 
using a custom Applied Biosystems TaqMan SNP Genotyping Assay (Thermo Fisher 221 
Scientific). For CNV analysis, commercial Taqman Copy Number assays (Thermo Fisher 222 
Scientific) were used for exon 2 of GJA8 and a reference gene (human RNase P gene). 223 
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RESULTS 224 
Point mutations identified in GJA8. 225 
Screening of the GJA8 coding region in our cohort of 426 individuals with AMC detected 10 226 
missense variants in 11 unrelated families (Tables 1 and 2). For each missense variant, the 227 
amino acid conservation across species is shown in the Supplementary Fig. 1. Taking into 228 
account the segregation patterns, the frequency of the variants in public databases of 229 
unaffected individuals (Table 2), in silico predictions of functional effects and previous 230 
reports from the literature (Table 2), as suggested by (Richards et al., 2015), six of these 231 
variants (p.(Thr39Arg), p.(Trp45Leu), p.(Asp51Asn), p.(Phe70Leu), p.(Gly94Arg) and 232 
p.(Val97Gly)) were considered likely causative, giving a frequency of 1.6% of independent 233 
individuals with AMC conditions (7/426) carrying likely pathogenic GJA8 sequence variants. 234 
In family 1 (Fig. 1a), the heterozygous variant p.(Thr39Arg) (NM_005267.4:c.116C>G) was 235 
identified in the male proband (III:1), who presented with bilateral microphthalmia, 236 
sclerocornea, cataracts and nystagmus, left secondary glaucoma and a grossly cupped 237 
atrophic disc (Fig. 1b). Extraocular anomalies were not observed. The Sanger sequencing 238 
profile was suggestive of mosaicism in his mother (II:2), who was diagnosed with early onset 239 
cataracts and right exotropia. Mosaicism was confirmed and quantified by ddPCR in blood 240 
samples, with an estimated fractional abundance of 25% for the mutated allele (Fig. 1c). The 241 
variant was absent in the maternal grandparents, suggesting that it arose as a de novo post-242 
zygotic event in the mother. The substitution of threonine 39, located in the TM1 domain, is 243 
predicted deleterious by Polyphen-2 and SIFT. Interestingly, the change p.(Thr39Arg) is 244 
absent in dbSNP147 and gnomAD, but has been previously described in a family with 245 
congenital cataracts, microcornea and iris hypoplasia (Sun et al., 2011). 246 
In family 2 (Fig. 1d), a four-generation pedigree with autosomal dominant congenital 247 
cataracts, we initially identified the variant p.(Trp45Leu) (NM_005267.4:c.134G>T) in the 248 
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proband III:2, who had a diagnosis of dense congenital cataracts, microphthalmia and 249 
nystagmus. Sanger sequencing was performed on five additional family members (four 250 
affected with the same clinical diagnosis and one unaffected) and showed that the variant co-251 
segregated with the ocular phenotype. The same amino acid substitution, predicted 252 
deleterious by Polyphen-2 and SIFT, has been previously described in another multi-253 
generation family including eleven individuals with autosomal dominant congenital cataracts 254 
(Mohebi et al., 2017). Moreover, a different missense variant affecting the same amino acid, 255 
p.(Trp45Ser) (NM_005267.4:c.134G>C, rs864309688), has been reported in a three 256 
generation family with bilateral congenital cataracts and microcornea (Vanita et al., 2008), in 257 
a sporadic case with bilateral anterior cortical/nuclear cataracts (Ma et al., 2016) and in a 258 
three generation family with paediatric cataracts (Javadiyan et al., 2017). Functional 259 
experiments showed that p.(Trp45Ser) inhibited the formation of functional intercellular 260 
channels or hemichannels and decreased the junctional conductance induced by wild-type 261 
Cx50 and Cx46, acting as dominant negative inhibitor (Tong et al., 2011). Tryptophan 45 is 262 
an evolutionary conserved residue located in the TM1 domain and its substitution with 263 
leucine or serine has not been observed in controls (gnomAD).  264 
In family 3 (Fig. 1e) and family 4 (Fig. 1f), we identified the variant p.(Asp51Asn) 265 
(NM_005267.4:c.151G>A; rs864309703), which affects a highly conserved amino acid 266 
located in the ECL1 domain. This change, predicted deleterious by Polyphen-2 and SIFT, has 267 
been previously reported in a patient with bilateral microphthalmia, congenital cataracts and 268 
sclerocornea (Ma et al., 2016; Ma et al., 2018). In family 3, the mutation occurred as a de 269 
novo event in the male proband, who presented with bilateral microphthalmia with associated 270 
cataracts, anterior segment dysgenesis and persistent pupillary membranes. Extraocular 271 
anomalies were not observed. In the three-generation family 4, the heterozygous variant was 272 
identified in both the proband (III:1) and her affected father (II:4). Head axial computed 273 
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tomography scanning of the proband at 29 years old showed borderline bilateral 274 
microphthalmia and enophthalmos (posterior displacement of the eye), although her ocular 275 
globes had a size of 20mm (right eye) and 18mm (left eye). At 32 years of age, the proband 276 
had no light perception on the right and light perception on the left. The right eye was 277 
phthisical, with no discernible anterior segment structures; the left eye had a corneal 278 
leukoma, cataract and corectopia. The father was diagnosed with bilateral microphthalmia 279 
and congenital cataracts. The paternal grandfather (I:1) and one of the paternal uncles (II:3), 280 
now deceased, were also affected. The mother (II:5) was affected by congenital glaucoma. 281 
However, the proband did not carry a mutation in any known congenital glaucoma-associated 282 
genes included in a custom targeted NGS panel containing 121 eye developmental genes, 9 of 283 
which are associated with congenital glaucoma. No extraocular anomalies were observed.  284 
In family 5 (Fig. 1g), the novel variant p.(Phe70Leu) (NM_005267.4:c.208T>C) was 285 
identified in the proband III:2, diagnosed with bilateral microphthalmia, congenital cataracts 286 
and secondary glaucoma. Segregation analysis showed that the mutation was a de novo event 287 
in the affected mother (II:2), who also had microphthalmia and cataracts. Phenylalanine 70 is 288 
a conserved amino acid located in the ECL1 domain, and its substitution is predicted to be 289 
deleterious by SIFT and Polyphen-2. 290 
In family 6 (Fig. 1h), we identified a missense variant p.(Gly94Arg) 291 
(NM_005267.4:c.280G>A) in a male proband of Chinese ethnicity (II:1) presenting with 292 
bilateral congenital aphakia (absence of the lens), corneal opacity, bilateral microphthalmia 293 
with iris and optic disc coloboma, and bilateral primary glaucoma. No extraocular anomalies 294 
were observed. No details of parental phenotype or DNA were available. Interestingly this 295 
change, predicted deleterious by SIFT and Polyphen-2 and located in the TM2 domain, is 296 
absent in gnomAD, but has been previously identified as a de novo event in a child with 297 
bilateral corneal opacification and microcornea, bilateral rudimentary lenses and bilateral 298 
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glaucoma (Ma et al., 2018).  299 
In family 7 (Fig. 1i), the female proband (II:1) carried a de novo variant p.(Val97Gly) 300 
(NM_005267.4:c.290T>G), predicted deleterious by SIFT and Polyphen-2 and located in the 301 
TM2 domain. This previously undescribed variant was identified by the DDD study 302 
(DECIPHER ID: 259194) and confirmed with Sanger sequencing. She had bilateral 303 
microphthalmia, anterior segment dysgenesis and dense cataracts, treated with lensectomies, 304 
and right secondary glaucoma, with no extraocular features.  305 
The significance of the other four variants identified in the screening (Supplementary Fig. 2) 306 
was considered ‘uncertain’ (p.(Leu292Gln)) or ‘unlikely to be pathogenic’ (p.(Leu7Met), 307 
p.(Asn220Asp) and p.(Gly333Arg)).  308 
A novel amino acid change, p.(Leu292Gln) (NM_005267.4:c.875T>A) was identified in a 309 
proband with bilateral mild cataracts and optic nerve coloboma associated with nystagmus, 310 
photophobia and small kidneys (family 8). The substitution of leucine 292, located in the CT 311 
domain, is predicted benign by SIFT, but deleterious by Polyphen-2. Sanger sequencing of 312 
PAX2 revealed that the proband II:3 also carried a novel heterozygous frameshift variant in 313 
this gene (NM_003987.2:c.529_530ins13, p.(Ala177Glyfs*8)), which introduces a premature 314 
stop codon in exon 5. Sanger sequencing excluded the maternal inheritance of both the GJA8 315 
and the PAX2 variants; paternal DNA was unavailable for segregation analysis. 316 
The GJA8 variant p.(Leu7Met) (NM_005267.4:c.19C>A; rs150441169), located in the N-317 
terminal domain and predicted deleterious by SIFT and Polyphen-2, was detected in a patient 318 
(II:1) with syndromic unilateral microphthalmia, and was inherited from his unaffected father 319 
(family 9). The family is of African ethnicity and the minor allele frequency (MAF) for the 320 
African/African-American population in gnomAD is 0.28%. Different substitutions of this 321 
amino acid have been described before as disease-causative mutations: p.(Leu7Pro) 322 
(NM_005267.4:c.20T>C) was identified in a family with inherited cataracts (Mackay et al., 323 
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2014) and p.(Leu7Gln) (NM_153465.1:c.20T>A) in a rat model with nuclear pulverulent 324 
cataracts and, in the case of homozygous rat mutants, microphthalmia with hypoplastic lens 325 
(Liska et al., 2008). However, in contrast with these previously reported variants, the 326 
frequency of the p.(Leu7Met) variant in unaffected individuals, in particular of African/Afro-327 
American ethnicity, suggests that the substitution with a methionine might be tolerated. 328 
The variant p.(Asn220Asp) (NM_005267.4:c.658A>G; rs138140155, gnomAD total-329 
MAF=0.24%) was identified in an individual with bilateral microphthalmia and chorioretinal 330 
colobomas involving the optic disc, as well as microcephaly associated with normal 331 
development and faltering growth (family 10) and was inherited from her unaffected father. 332 
This substitution of asparagine 220, located in the TM4 domain and predicted deleterious by 333 
SIFT and Polyphen-2, has been reported before in a proband with congenital cataract and 334 
microcornea (Ma et al., 2016) and in a three generation family with congenital cataracts and 335 
aphakic glaucoma (Kuo et al., 2017). However, in those families it did not co-segregate with 336 
the phenotype and therefore was classified as benign. This was also supported by functional 337 
experiments showing that this rare polymorphism did not abolish intercellular channel 338 
function (Kuo et al., 2017). 339 
The variant p.(Gly333Arg) (NM_005267.4:c.997G>C; rs587600450, gnomAD total-340 
MAF=0.009%) was observed in a proband with unilateral microphthalmia and chorioretinal 341 
coloboma involving the optic disc, and was inherited from her unaffected father (family 11). 342 
This heterozygous change occurs in the CT domain and is predicted as tolerated by both SIFT 343 
and Polyphen-2.  344 
1q21 copy number variants overlapping with GJA8. 345 
GJA8 is part of a complex genomic locus, 1q21.1-q21.2, characterised by the presence of 346 
numerous segmental duplications (SDs), which make the region susceptible to recurrent 347 
rearrangements. To investigate whether structural variants affecting GJA8 were present in our 348 
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cohort of families with AMC, we examined a subset of 188 unrelated individuals for whom 349 
copy number information was available from aCGH and/or NGS data. As such, the samples 350 
for which CNV data were generated were not chosen according to any selection criteria 351 
applied across the total cohort, and therefore they effectively represented a randomly-selected 352 
subset of independent AMC cases. This resulted in the identification of 1q21 microdeletions 353 
in five families (Fig. 2, Table 1).  354 
The first microdeletion was identified in a proband (family 12, Fig. 2b) with bilateral 355 
coloboma of the iris and choroid, mild dysmorphic features (broad forehead, narrow 356 
palpebral fissures, depressed nasal root and low set ears), scoliosis, genu valgum and 357 
gastroesophageal reflux. She had normal developmental milestones. This CNV, detected 358 
from the screening of a custom NGS panel of 121 eye development genes, was further 359 
confirmed by both aCGH and ddPCR (Supplementary Fig. 3). It spans approximately 2 Mb 360 
(chr1:145388977-147395401, Build GRCh37/hg19) and affects 40 RefSeq genes. 361 
Segregation analysis revealed that this structural variant arose as a de novo event in the 362 
proband.  363 
The second microdeletion was identified in a female proband with unilateral chorioretinal 364 
coloboma involving the optic disc, band keratopathy, cataract and secondary glaucoma 365 
without extraocular anomalies, and was inherited from her unaffected father (family 13, Fig. 366 
2b). The minimal deleted region (chr1:146155983-147824178, Build GRCh37/hg19) spans 367 
approximately 1.67 Mb and affects 24 RefSeq genes. To validate the microdeletion and test 368 
the hypothesis that the unaffected status of the father could be due to mosaicism, we 369 
performed a ddPCR assay. However, this experiment confirmed the full heterozygous status 370 
of the microdeletion in both individuals (Supplementary Fig. 3b).  371 
The third microdeletion was found in a female proband with extreme microphthalmia in the 372 
right eye and iris, chorioretinal coloboma in the left eye, cleft lip and palate, and neonatal 373 
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seizures (family 14, Fig. 2b). The minimal deleted region (chr1:146564743-147735011, Build 374 
GRCh37/hg19) spans approximately 1.17 Mb and affects 17 RefSeq genes. The presence of 375 
the CNV in the mother was excluded by ddPCR (Supplementary Fig. 3b). The father and 376 
other family members were unavailable for phenotypic and segregation analysis.  377 
The fourth microdeletion (chr1:146497694-147825519, Build GRCh37/hg19), spanning 378 
approximately 1.33 Mb and affecting 20 RefSeq genes, was identified in two independent 379 
families (families 15 and 16, Fig. 2b). In family 15, it occurred as a de novo event in a 380 
proband with bilateral iris and chorioretinal coloboma involving disc, and nystagmus, without 381 
extraocular anomalies. The presence of the CNV in the parents was excluded by aCGH. 382 
Clinical re-assessment of the family revealed that the father presented blue dot lens opacities 383 
and cavernous disc anomalies with a pit in the right eye and mild cavernous disc anomaly or 384 
pronounced optic cup in the left eye. In family 16, a three-generation pedigree with 385 
coloboma, the microdeletion was detected by aCGH in the proband (III:6), who showed 386 
bilateral chorioretinal coloboma and microphthalmia in the right eye associated with 387 
microcephaly and normal development, and in the affected father (II:5), who presented with 388 
microphthalmia and coloboma in the right eye. The cousin III:2 was also affected with 389 
unilateral iris and chorioretinal coloboma. However, segregation analysis could not be 390 
performed on this individual. 391 
The predicted boundaries of these CNVs indicated that these rearrangements belonged to 392 
different classes of 1q21 microdeletions. Recurrent 1q21 CNVs occur at four breakpoint 393 
regions (BP1-BP4), each corresponding to a large block of highly homologous SDs (Mefford 394 
et al., 2008). Further, the locus can be divided into two distinct regions: a proximal region 395 
included between BP2 and BP3 and a distal region, flanked by BP3 and BP4, which mediate 396 
the most recurrent CNVs of the 1q21 locus. While the microdeletions found in families 13-16 397 
were distal rearrangements occurring between BP3 and BP4 (class I), the microdeletion 398 
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detected in family 12 was flanked by the breakpoints BP2 and BP4 and extended from the 399 
proximal through to the distal region (class II). Despite their rarity in the general population, 400 
both types of 1q21 microdeletions appeared to be enriched in our AMC cohort. We compared 401 
the frequency of these CNVs in our cases with control individuals previously reported in the 402 
literature (Rosenfeld et al., 2012): BP3-BP4 microdeletions occurred in 4 out of 188 403 
individuals with AMC versus 12 out of 65282 controls (2.13% versus 0.02%, Fisher’s exact 404 
test p=1.17 x 10-7), whereas BP2-BP4 microdeletions occurred in 1 out of 188 individuals 405 
with AMC versus 1 out of 65927 controls (0.532% versus 0.002%, Fisher’s exact test 406 
p=0.0057).  407 
Taking into account all the 1q21 microdeletions identified in our cohort, the minimally 408 
deleted region spans approximately 830 kb (chr1:146564743-147395401, Build 409 
GRCh37/hg19) and includes 11 genes (NBPF19, NBPF13P, PRKAB2, CHD1L, PDIA3P1, 410 
FMO5, LINC00624, BCL9, ACP6, GJA5, GJA8). In addition to Gja8, a role in eye 411 
development has been shown also for Bcl9, a co-activator for β-catenin-mediated 412 
transcription in Wnt signaling (Bienz, 2005). A recent study has demonstrated that Bcl9 is 413 
also part of the Pax6-dependent regulatory circuit and contributes to mouse lens formation 414 
(Cantù et al., 2014). No other genes known to be relevant in eye development are present in 415 
the region. 416 
Sequence analysis of the coding region of GJA8 in the probands carrying 1q21 417 
microdeletions did not reveal any variant on the remaining allele. In family 12, no additional 418 
pathogenic variants were identified from the targeted NGS screening of 121 eye 419 
developmental genes. In family 13, the NGS targeted sequencing of 351 diagnostic genes for 420 
eye developmental anomalies in proband II:2 identified an in-frame deletion of 6bp in 421 
FOXC1 (NM_001453.2:c.1338_1343del, p.(Gly447_Gly448del)), maternally inherited. This 422 
rare variant (gnomAD total-MAF=0.06%) is reported as a multi-allelic SNP (rs572346201), 423 
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which occurs in a region coding for a poly-Glycine stretch. Although its clinical significance 424 
is unknown, due to the repetitive nature of this region, it is likely to represent a natural 425 
polymorphism.  426 
DISCUSSION 427 
Mutations in Cx50, encoded by GJA8, have been primarily linked to congenital and early 428 
onset cataract in humans and also animal models. However, recently in a small number of 429 
cases GJA8 mutations have also been associated with a broader phenotype which can include 430 
microphthalmia, sclerocornea and lens abnormalities (Ma et al., 2018).  431 
In this study, we have investigated the role of GJA8 in a cohort of 426 individuals with a 432 
wide range of developmental eye anomalies, and identified 16 families with AMC carrying 433 
genetic alterations of GJA8. These included six likely pathogenic sequence variants 434 
(p.(Thr39Arg), p.(Trp45Leu), p.(Asp51Asn), p.(Phe70Leu), p.(Gly94Arg) and p.(Val97Gly)) 435 
detected in seven unrelated families, four missense variants (p.(Leu7Met), p.(Asn220Asp), 436 
p.(Leu292Gln) and p.(Gly333Arg)) with uncertain or unlikely clinical significance and four 437 
heterozygous 1q21 microdeletions involving GJA8 detected in five unrelated families of 438 
uncertain significance.  439 
Segregation analyses were possible for five out of six likely pathogenic sequence variants and 440 
showed that these occurred either de novo or co-segregated with the disease in an autosomal 441 
dominant fashion. These variants were bioinformatically predicted damaging and have not 442 
been reported in unaffected individuals according to public databases. Interestingly, three of 443 
these changes (p.(Thr39Arg), p.(Trp45Leu) and p.(Asp51Asn)) have been previously 444 
described in families with cataracts (Sun et al., 2011; Ma et al., 2016; Javadiyan et al., 2017; 445 
Mohebi et al., 2017; Ma et al., 2018) and a fourth (p.(Gly94Arg)) in a proband with 446 
sclerocornea and lens abnormalities (Ma et al., 2018). Given the rarity of these variants, the 447 
identification of the same missense changes in unrelated affected individuals strongly 448 
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supports a causative relationship between these variants and eye developmental disorders. In 449 
particular, p.(Asp51Asn) had been reported as a de novo mutation in a patient with bilateral 450 
microphthalmia, congenital cataracts and sclerocornea (Ma et al., 2016). In the present study, 451 
the same variant was detected in two independent families with a similar phenotype, 452 
including microphthalmia, cataracts and other anterior chamber eye anomalies. This 453 
emerging genotype-phenotype correlation suggests that this amino acid substitution might 454 
have a severe effect on GJA8 function and supports the involvement of this protein in a 455 
broader range of eye developmental anomalies.  456 
Our identification of the variant p.(Gly94Arg) in another patient also aids genotype-457 
phenotype correlation for amino acid substitutions of this highly conserved residue. In our 458 
cohort, the change was identified in a case with bilateral corneal opacification, congenital 459 
aphakia and microphthalmia with iris and optic disc coloboma. The same variant has been 460 
previously reported as a de novo event in an individual diagnosed with bilateral corneal 461 
opacification, glaucoma, and rudimentary lenses (Ma et al., 2018). Interestingly, Ma et al. 462 
(2018) also described another variant affecting the same amino acid, p.(Gly94Glu), in a 463 
proband with total sclerocornea and cataractous disc-like lenses with microcornea. Mice 464 
models expressing heterozygous missense mutations (e.g. Cx50D47A, Cx50S50P, 465 
Cx50V64A and Cx50R205G) (Graw et al., 2001; Xia et al., 2006; Xia et al., 2012; Berthoud 466 
et al., 2013) or with complete Gja8 knockout (White et al., 1998; Rong et al., 2002) have 467 
shown that Gja8 is important for lens development. Therefore, the identification of glycine 94 468 
mutations in three individuals with lens abnormalities supports the hypothesis that this amino 469 
acid is particularly important for GJA8 to perform this role in eye development. Interestingly, 470 
the phenotype of bilateral aphakia associated with sclerocornea overlaps with that of 471 
individuals with biallelic mutations in FOXE3 (Iseri et al., 2009). Therefore, when screening 472 
patients with this phenotype, it is important to screen for variants in both FOXE3 and GJA8.  473 
21 
 
Multiple sequence alignment indicated that all likely pathogenic sequence variants identified 474 
in our cohort affected conserved residues (Supplementary Fig. 1) and were located within the 475 
N-terminal region of the protein (Fig. 3). Our findings are consistent with previous studies, 476 
since mutations associated with cataracts tend to cluster between TM1 and TM2 (Yu et al., 477 
2016). The transmembrane domains are thought to play an important role in oligomerisation 478 
and pore formation, while the ECL1 domain is important in the docking of two opposing HCs 479 
to form the GJCs. While these domains are evolutionarily conserved and present high 480 
homology among the members of the Cx family, the CT region is the most isotype-specific 481 
domain and contains motifs for regulatory kinases (Liu et al., 2011; Wang et al., 2013). In 482 
this region, we identified a novel missense change, p.(Leu292Gln), of unknown clinical 483 
significance. The variant was found in a proband (family 8) who also carried an insertion of 484 
13bp in PAX2 (NM_003987.2:c.529_530ins13, p.(Ala177Glyfs*8)). Heterozygous variants 485 
of PAX2 (MIM 167409) are identified in approximately half of the cases presenting with 486 
renal coloboma syndrome (Bower et al., 2012), also known as papillorenal syndrome (OMIM 487 
120330). Therefore, this novel PAX2 variant is likely to be responsible for optic nerve 488 
coloboma and kidney anomalies observed in the patient, but it is possible that the GJA8 489 
variant might lead to a subtle effect on the protein function and contribute to his mild cataract 490 
phenotype.  491 
By contrast, the three additional heterozygous variants p.(Leu7Met) (family 9), 492 
p.(Asn220Asp) (family 10) and p.(Gly333Arg) (family 11) were considered as likely benign. 493 
These were identified in individuals with AMC, but without cataracts, in unaffected parents 494 
either in this or previous studies (Ma et al., 2016; Kuo et al., 2017) and in controls 495 
(gnomAD).  496 
Human GJA8 maps to a structurally complex locus on chromosome 1q21.1-q21.2, with at 497 
least four large blocks of highly homologous SDs, which make it prone to nonallelic 498 
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homologous recombination (NAHR) (Mefford et al., 2008). As with other genomic loci 499 
subject to recurrent rearrangements (such as 15q11, 15q13, 16p11.2, 16p12.1, 16p13.11, 500 
17q12, 22q11.2) (Girirajan and Eichler, 2010; Stankiewicz and Lupski, 2010), 1q21 CNVs 501 
have been associated with a wide range of phenotypes including dysmorphic features, 502 
developmental delay, neuropsychiatric disorders, and cardiac and eye anomalies. The 503 
reported eye anomalies include cataracts (Brunetti-Pierri et al., 2008; Mefford et al., 2008; 504 
Rosenfeld et al., 2012; Bernier et al., 2016; Ha et al., 2016) and in a minority of cases more 505 
severe defects such as microphthalmia (Mefford et al., 2008) and coloboma (Brunetti-Pierri et 506 
al., 2008). 507 
The most common 1q21 CNVs occur between the breakpoints BP3 and BP4 (Fig. 2a), 508 
spanning ∼1.35 Mb (Mefford et al., 2008). This region contains only ∼800 kb of unique (i.e. 509 
nonduplicated) DNA sequence (Bernier et al., 2016) and includes at least 11 genes (NBPF19, 510 
NBPF13P, PRKAB2, CHD1L, PDIA3P1, FMO5, LINC00624, BCL9, ACP6, GJA5 and 511 
GJA8), which might contribute to different aspects of the disease manifestations observed. 512 
Alternatively, 1q21 CNVs can involve only the proximal region (BP2-BP3) or both the 513 
proximal and the distal region (BP1/BP2-BP4). Microdeletions of the proximal region have 514 
been reported to be a predisposing factor for Thrombocytopenia-absent radius (TAR) 515 
syndrome (Klopocki et al., 2007), together with sequence variants in the RBM8A gene. 516 
Within the distal region, a potential role in eye development has been shown for two of the 517 
genes, GJA8 and BCL9. A recent study has demonstrated that Bcl9 is a downstream effector 518 
of Pax6 during mouse lens development (Cantù et al., 2014). However, the role of BCL9 in 519 
human eye development has not yet been established. Given the involvement of GJA8 in both 520 
cataractogenesis and ocular growth, as previously described, this gene seems to be a good 521 
candidate for the ocular anomalies observed in some of the 1q21 CNV carriers.  522 
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In most cases, the 1q21 rearrangements are inherited. Their presence in unaffected parents 523 
has brought into question their pathogenic significance, but the analysis of large clinical and 524 
population cohorts has shown that 1q21 microdeletions/microduplications occur at 525 
significantly higher frequency in individuals with clinical diagnoses compared with controls 526 
(Brunetti-Pierri et al., 2008; Mefford et al., 2008; Rosenfeld et al., 2012; Bernier et al., 2016). 527 
In particular, the comparison of a large cohort of individuals with developmental delay, 528 
intellectual disability, dysmorphic features and congenital anomalies with previously 529 
published control cohorts showed that the frequency of BP2-BP4 deletions was 0.024% in 530 
cases (11/45744) versus 0.002% in controls (1/65927), whereas the frequency of BP3-BP4 531 
deletions was 0.285% in cases (86/30215) versus 0.018% in controls (12/65282) (Rosenfeld 532 
et al., 2012). This enrichment suggests that these CNVs might increase susceptibility to 533 
developmental anomalies with variable expressivity and incomplete penetrance, although the 534 
factors underlying their heterogeneous phenotypes remain unexplained. In this study, we 535 
identified four microdeletions in five families, three overlapping with the 536 
microdeletions/microduplications recurrently found between breakpoints BP3 and BP4 and 537 
one larger BP2-BP4 microdeletion encompassing both the proximal and the distal region. 538 
Given the rarity of these rearrangements, the presence of 1q21 microdeletions in our AMC 539 
cohort, with a frequency of 2.13% in AMC cases for BP3-BP4 microdeletions (p=1.17 x 10-7) 540 
and a frequency of 0.53% in AMC cases for BP2-BP4 microdeletions (p=0.0057), seems to 541 
support their role as a risk factor for developmental disorders, including eye anomalies. 542 
However, consistent with previous studies, the segregation pattern in families 13 and 15 543 
indicates that other genetic and/or environmental modifiers are likely to be important for the 544 
phenotypic outcome. Therefore, the exact genotype-phenotype correlation remains to be 545 
established.  546 
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Mouse models have shown that Gja8 copy number losses and point mutations act through 547 
different mechanisms and modes of inheritance. Deletions of the entire coding region of the 548 
gene cause cataracts and microphthalmia only when homozygous, indicating a recessive 549 
mode of inheritance (White et al., 1998; Rong et al., 2002). In contrast, mouse strains 550 
carrying pathogenic Gja8 missense mutations develop microphthalmia and cataracts in a 551 
dominant or semi-dominant fashion (Steele et al., 1998; Graw et al., 2001; Chang et al., 2002; 552 
Liska et al., 2008; Xia et al., 2012). Since Cxs function in hexameric complexes which can be 553 
homo- or heteromeric, it is possible that the impact of single amino acid substitutions may be 554 
more severe than the loss of one functional allele. Mutant Cx subunits can interfere with 555 
correct formation of the oligomeric complexes in a dominant negative manner and, since 556 
GJCs can be formed by different types of Cx subunits, this effect can also extend to the 557 
function of other Cxs. Functional and cellular studies have shown that point mutations can 558 
alter the activity of the human GJA8 protein in various ways (Beyer et al., 2013). For 559 
instance, pathogenic variants can cause misfolding, improper oligomerisation and/or 560 
trafficking defects, leading to a reduced number of functional channels on the membrane. 561 
Alternatively, the pathogenic variants could alter some physiological properties of the 562 
channels, such as permeability or conductance, or lead to the formation of HCs with new and 563 
aberrant functions. Therefore, a single base mutation can affect several aspects of the Cx 564 
function. This complexity may explain the phenotypic heterogeneity observed among the 565 
carriers of GJA8 variants, and also the difference in penetrance between sequence and copy 566 
number variations.  567 
Intra-familial phenotypic variability was also observed for the sequence variant identified in 568 
family 1 (p.(Thr39Arg)) possibly related to mosaicism. While the proband carrying the 569 
heterozygous change presented with bilateral cataracts and microphthalmia, his mother, who 570 
was 25% mosaic for this variant, had a milder phenotype of early onset cataracts. Therefore, 571 
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we hypothesize that the somatic mosaicism detected in the mother may explain her milder 572 
phenotype and that lower doses of aberrant GJA8 protein during eye development might be 573 
responsible for less severe phenotypic outcomes. In support of this, a recent study has 574 
reported a correlation between the severity of developmental eye abnormalities and somatic 575 
mosaicisms of Pax6 mutations in CRISPR/Cas9 genome-edited mouse embryos (Yasue et al., 576 
2017). 577 
In conclusion, this study expands our knowledge of the role of GJA8 in eye development, 578 
highlighting how genetic alterations of this gene are likely to give rise not only to early onset 579 
cataracts, but also to other developmental eye anomalies. The screening of GJA8 in 426 580 
individuals with AMC resulted in the identification of six likely pathogenic variants in seven 581 
families. In the six families where segregation analysis was possible, the variants co-582 
segregated with both early onset cataracts and microphthalmia. In one singleton case with 583 
aphakia and corneal opacification where no segregation analysis was possible, we identified 584 
the variant p.(Gly94Arg). This finding, in combination with two previously reported patients 585 
with lens development abnormalities and with variants affecting the same amino acid, 586 
highlights the importance of this specific residue in the function of GJA8 and suggests that 587 
GJA8 mutations can be responsible for phenotypes often associated with FOXE3 variants. 588 
The role of GJA8 microdeletions in AMC remains uncertain: the enrichment of rare 1q21 589 
microdeletions in our cohort seems to support their role as risk factors for developmental eye 590 
disorders. However, the incomplete segregation and the phenotypic variability of these 591 
variants indicate that other genetic and/or environmental factors might be of importance. In 592 
summary, these data expand the spectrum of human phenotypes associated with GJA8 593 
variants and the identification of specific mutations contributes to our understanding of their 594 
genotype-phenotype correlation. Therefore, this study demonstrates the importance of 595 
screening GJA8 in individuals with developmental eye anomalies.  596 
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FIGURE LEGENDS 828 
Fig. 1 GJA8 likely pathogenic sequence variants identified in 7 unrelated families with 829 
AMC. a. Pedigree of family 1. Sanger sequencing results showing the segregation of the 830 
missense variant p.(Thr39Arg) are presented. The chromatogram of individual II:2 is 831 
suggestive of mosaicism. b. Photographs of the affected individuals of family 1 showing 832 
intra-familial phenotypic variability. The mother (II:2, top) presented with a milder 833 
phenotype, which included right exotropia and normal sized eyes with bilateral 834 
pseudophakia. The proband (III:1, bottom) presented with right microphthalmia and complete 835 
corneal opacification on the left. c. Absolute quantification of the allele abundance for the 836 
variant c.116C>G; p.(Thr39Arg) in family 1. Digital Droplet PCR (ddPCR) assays were 837 
performed using a Taqman FAM-labeled probe for genotyping the mutant allele and a VIC-838 
labeled probe to detect the wild-type allele. On the left, 1-D fluorescence amplitude plot of 839 
droplets shows mutant allele detection in the FAM channel for the heterozygous carrier 840 
(III:1), the putative mosaic mother (II:2), a wild-type homozygous carrier (I:2) and no 841 
template control (NTC). FAM-positive droplets (blue), containing the mutant allele, exhibit 842 
increased fluorescence compared to negative droplets (grey). On the right, the fractional 843 
abundance of the mutated allele, represented in percentage, was calculated for the FAM-844 
positive droplets versus VIC-positive droplets (wild type allele), confirming the mosaicism of 845 
this variant in individual II:2. d. Pedigree of family 2. On the left, a representative sequence 846 
chromatogram shows the heterozygous missense variant p.(Trp45Leu). The genotype of the 847 
six individuals tested for the variant is indicated below each symbol. e-f. Pedigree of families 848 
3 and 4, both carrying the missense variant p.(Asp51Asn). The sequence chromatograms 849 
show that the variant occurred de novo in family 3. N/A, genotype not available. In family 4, 850 
representative sequence chromatogram showing the p.(Asp51Asn) and pedigree indicating 851 
the inheritance of affected status and of the variant. For family 4, fully filled symbols 852 
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represent individuals affected with congenital cataracts and microphthalmia, but without 853 
glaucoma, quarter filled symbols represent individuals with congenital glaucoma. g. Pedigree 854 
of family 5 and sequence chromatograms showing the missense variant p.(Phe70Leu). h. 855 
Pedigree of family 6. The adopted child carries the missense variant p.(Gly94Arg). i. 856 
Pedigree of family 7. Sanger sequencing results show that the missense variant p.(Val97Gly) 857 
arose de novo in the child II:1 858 
Fig. 2 GJA8 structural variants identified in 5 unrelated families with AMC. a. Modified 859 
schematic from the UCSC Genome Browser (NCBI Build GRCh37/hg19). Partial ideogram 860 
of the chromosome bands 1q21.1-q21.2 and the multiple blocks of highly homologous 861 
segmental duplications (SD) present in this region are shown. SD, reported under the UCSC 862 
track 'Duplications of >1000 Bases of Non-RepeatMasked Sequence', are stretches of DNA 863 
of at least 1 kb in length, sharing a sequence identity of at least 90% with another genomic 864 
region on the same or on a different chromosome (inter- or intra-chromosomal SD). The 865 
colours indicate different levels of similarity between duplications (grey: 90-98% similarity, 866 
yellow: 98-99% similarity, orange: greater than 99% similarity). The breakpoint regions 867 
(BP2, BP3 and BP4) overlapping with these SD clusters are represented by green bars. The 868 
genomic locations of the 1q21 deletions identified in this study are represented by red bars 869 
and indicated with family identifiers. RefSeq Genes are indicated by dark-blue rectangular 870 
bars. For genes with multiple isoforms, the bars represent the coordinates of the maximal 871 
region among the isoforms. b. Pedigrees of the families carrying heterozygous 1q21 deletions 872 
Fig. 3 GJA8 mutation spectrum. Schematic of GJA8 showing the protein domains 873 
according to UniProt (entry ID: P48165). Above: previously published mutations are shown. 874 
Below: the missense variants identified in our cohort are indicated: red indicates likely 875 
pathogenic, blue, likely benign and grey, unknown clinical significance. NT, N-terminal 876 
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domain; TM, transmembrane domain; ECL, extracellular loop; ICL, cytoplasmic loop; CT, 877 
C-terminal domain 878 
